A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis

• DOI: 10.1007/s15010-020-01561-x
• Publication Date: 2020-12-17T16:04:12Z
• Authors: Daniela Pasero; Silvana Sanna; Corrado Liperi; Davide Piredda; Gian Pietro Branca; Lorenzo Casadio; Raffaella Simeo; Alice Buselli; Davide Rizzo; Francesco Bussu; Salvatore Rubino; Pierpaolo Terragni
• Keywords: Opportunistic infection; Coronavirus

Abstract Severe acute respiratory syndrome coronavirus 2 infection might induce a significant and sustained lymphopenia, increasing the risk of developing opportunistic infections. Mucormycosis is rare but severe invasive fungal infection, mainly described in immunocompromised patients. The first case patient diagnosed with disease (COVID-19) who developed pulmonary mucormycosis extensive cavitary lesions here reported. This highlights how this new impair immune response, exposing patients to higher infections leading worse outcomes.